Skip to content

Comparison of the effects of lavender and citrus aurantium inhalation on the severity of primary dysmenorrhea

Comparison of the effects of lavender and citrus aurantium inhalation on the severity of primary dysmenorrhea in female students: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210220050418N2
Enrollment
44
Registered
2023-10-11
Start date
2023-11-22
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea in female students. Primary dysmenorrhoea

Interventions

Intervention 1: Intervention group: After identifying the individuals, each of them is asked to record their pain intensity using the Visual Analogue Scale in the first and second cycles of the interv

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: willingness and informed consent to participate in the research having a regular menstrual cycle with a duration of 2-6 days and an interval of 21-35 days between periods onset of menstruation before the age of 15 primary dysmenorrhea with a score of 5 or more in the Visual Analogue Scale of pain during two consecutive cycles age 18-25 years being single being Iranian lack of known mental or physical illness (according to the statements of the research participant) absence of gynecological disease (myoma, endometriosis, ovarian cyst , pelvic inflammatory disease, etc.) (according to the statements of the research participant) having a normal sense of smell no history of allergies

Exclusion criteria

Exclusion criteria: not wanting to participating in the study having an allergy to citrus aurantium having an allergy to lavender

Design outcomes

Primary

MeasureTime frame
Measurable primary outcome: dysmenorrhea pain intensity, measured by the Visual Analogue Scale. Timepoint: Dysmenorrhea pain intensity is measured in 4 cycles, two menstrual cycles before the start of the intervention, and two menstrual cycles after the entry of the study subjects for the intervention. Method of measurement: After defining the groups, each of them is asked to record their pain intensity using the Visual Analogue Scale in the first and second cycles of the intervention. If the pain score is 5 or more than 5 in the first cycle before the intervention, the pain intensity of the people will be measured in the second cycle as well. If they have 5 or more points in two consecutive cycles, people will be included in the study. The pain intensity of people in the second cycle will be evaluated as the pain intensity before the intervention. The intervention of this research was carried out in the third and fourth menstrual cycle of the research units and the effect of inhaled drugs will be investigated. People are asked to record and inform the type, dosage and exact time of use if they take any painkillers at the time of study. In order to ensure that the intervention is performed after the maximum effect of the painkiller and to prevent its effect from interfering with the desired intervention, it is necessary to accurately record the time of use of each painkiller so that the aromatherapy intervention can be performed after the effectiveness of the painkiller is lost. In the third and fourth menstrual cycles of the study subjects, on the first and second days of the cycle, the intervention will be performed and on the third day, the pain intensity of the subjects will be recorded in the presence of the researcher (the subjects will be asked to inform the researcher of the time of menstruation and record their symptoms in the questionnaire). In this study, distilled water will be used as a placebo. Bottles containing distilled water and citrus aurantium an

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Bostani Khalesi

Rasht University of Medical Sciences

z_bostani@yahoo.com+98 13 3355 5001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026